ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019
Clinical Practice Variation Among Adult Infectious Disease Physicians in the Management of Staphylococcus aureus Bacteremia.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07148960 (Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?), which is not on this map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes? (SABEDTIO) Clinical Trial
Who cites it
23 citing papers in PubMed.
- Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-SensitiveOpen forum infectious diseases · 2024Trial
- Treatment of Methicillin-ResistantMedicines (Basel, Switzerland) · 2026Review
- The Effect of Transesophageal Echocardiogram on Clinical Outcomes for Patients withAntibiotics (Basel, Switzerland) · 2026Article
- Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicatedMicrobiology spectrum · 2025Observational
- Impact of a Bundle of Interventions on Quality-of-Care Indicators forAntibiotics (Basel, Switzerland) · 2024Article
- Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Review
- Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Article
- Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists.JAC-antimicrobial resistance · 2023Article
- Persistent Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2023Review
- Methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Oral step-down forClinical infection in practice · 2022Article
- Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries.The Journal of antimicrobial chemotherapy · 2022Article
- Economic Analysis of Infectious Disease Consultation for Staphylococcus aureus Bacteremia Among Hospitalized Patients.JAMA network open · 2022Article
- Clindamycin adjunctive therapy for severeJAC-antimicrobial resistance · 2022Article
- Article
- UncomplicatedOpen forum infectious diseases · 2020Article
- Efficacy of Early Oral Switch with β-Lactams for Low-RiskAntimicrobial agents and chemotherapy · 2020Article
- Early Oral Antibiotic Switch forAntimicrobial agents and chemotherapy · 2020Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
Infectious disease management of Staphylococcus aureus bacteremia (SAB) was surveyed through the Emerging Infections Network. Although there were areas of consensus, we found substantial practice variation in diagnostic evaluation and management of adult patients with SAB. These findings highlight opportunities for further research and guidance to define best practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.